Innoviva, Inc.

INVA

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001080014

SEC filings (opens in a new tab)

No open-market purchases or sales by Innoviva, Inc. insiders were filed in the last 90 days; 308 institutions reported holding it in 13F filings for Q2 2026, worth $1.69B in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Innoviva, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023 All holders in Q1 2023

13F holders of INVA: Q1 2023 compared with Q2 2023
Measure	Q1 2023	Of which not filed for Q2 2023	Q2 2023	Change
Holders	193	1	198	+6
Shares	69.7M	13.0K	70.6M	+856.6K (+1.2%)
Value	$789.0M	$146.3K	$898.1M	+$109.3M (+13.9%)

1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held Innoviva, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to INVA in Q2 2023
Institution	Shares	Value	% of portfolio
Empowered Funds, LLC	192,893	$2.46M	0.09%
EA Series Trust	192,893	$2.46M	0.09%
Arrowstreet Capital, Limited Partnership	182,414	$2.32M	0.00%
HRT Financial LP	155,652	$1.98M	0.02%
Jackson Creek Investment Advisors LLC	72,595	$924.0K	0.37%
Connor, Clark & Lunn Investment Management Ltd.	65,731	$836.8K	0.00%
Dark Forest Capital Management LP	64,050	$815.4K	0.08%
Cubist Systematic Strategies, LLC	55,537	$707.0K	0.01%
Jennison Associates LLC	49,641	$631.9K	0.00%
Point72 Middle East FZE	32,786	$417.4K	0.02%
Ergoteles LLC	32,200	$409.9K	0.02%
Engineers Gate Manager LP	28,250	$359.6K	0.01%
Creative Planning	16,091	$204.8K	0.00%
Campbell & CO Investment Adviser LLC	14,484	$184.4K	0.03%
Jump Financial, LLC	13,102	$166.8K	0.01%
Lazard Asset Management LLC	12,470	$158.0K	0.00%
Evergreen Capital Management LLC	11,369	$144.7K	0.01%
MML Investors Services, LLC	10,947	$139.0K	0.00%
Hennion & Walsh Asset Management, Inc.	10,306	$131.0K	0.01%
Dynamic Technology Lab Private Ltd	10,217	$130.0K	0.02%
Aquatic Capital Management LLC	6,700	$85.0K	0.00%
First Manhattan Co	1,000	$12.7K	0.00%
Point72 Asset Management, L.P.	918	$11.7K	0.00%
Elequin Capital LP	440	$5.60K	0.00%
Parallel Advisors, LLC	356	$4.53K	0.00%
Ronald Blue Trust, Inc.	49	$1.00K	0.00%
25 LLC	41	$511	0.00%

Sold out (21)

Institutions that held Innoviva, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of INVA in Q2 2023
Institution	Shares, Q1 2023	Value, Q1 2023
Woodline Partners LP	499,442	$5.62M
AlphaCentric Advisors LLC	184,000	$2.07M
Allianz Asset Management GmbH	112,000	$1.26M
Schonfeld Strategic Advisors LLC	35,313	$397.3K
Truist Financial Corp	33,726	$379.4K
Aigen Investment Management, LP	32,036	$360.4K
Panagora Asset Management Inc	27,923	$314.1K
Caxton Associates LP	23,860	$268.4K
NinePointTwo Capital	23,093	$259.0K
Mirabella Financial Services LLP	21,736	$244.5K
Walleye Capital LLC	20,538	$231.1K
Gallacher Capital Management LLC	18,631	$209.6K
Acrisure Capital Management, LLC	17,451	$196.3K
Quantamental Technologies LLC	10,082	$113.4K
New Vernon Capital Holdings II LLC	8,304	$93.4K
Macquarie Group Ltd	5,700	$64.0K
Banque Cantonale Vaudoise	3,862	$43.0K
Quantbot Technologies LP	2,309	$26.0K
Belpointe Asset Management LLC	204	$2.29K
Group One Trading, L.P.	37	$416
Toronto Dominion Bank	2	$0

Not filed for Q2 2023 yet (1)

Institutions that held Innoviva, Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding INVA in Q1 2023 that haven't filed for Q2 2023
Institution	Shares, Q1 2023	Value, Q1 2023
Euclidean Technologies Management, LLC	13,005	$146.3K